Human RNA-binding proteins with prion-like domains
| Protein | RRM domain (Pfam PF00076) | RNA binding (GO:0003723) | Prion domain score | Prion domain rank | P-bodies and/or SGs? | Neurodegenerative disease? |
| TNRC6A | − | + | 42.1 | 9 | + | |
| FUS | + | + | 38.5 | 12 | + | ALS, FTLD |
| ATXN1 | − | + | 35.5 | 15 | SCA1 | |
| TAF15 | + | + | 33.2 | 22 | + | ALS, FTLD |
| EWSR1 | + | + | 32.3 | 25 | + | ALS, FTLD |
| HNRPDL | + | + | 31.5 | 27 | ||
| HNRNPD | + | + | 30.7 | 29.5 | ||
| HNRNPA2B1 | + | + | 29.9 | 32 | + | IBMPFD |
| ILF3 | − | + | 29.8 | 33 | ||
| HNRNPUL1 | − | + | 28.5 | 37 | ||
| HNRNPA1 | + | + | 28.2 | 38 | + | IBMPFD, ALS |
| HNRNPAB | + | + | 27.8 | 39 | ||
| HNRNPA3 | + | + | 27.2 | 41 | + | C9orf72 ALS/FTLD |
| TARDBP | + | + | 26.5 | 43 | + | ALS, FTLD |
| HNRNPU | − | + | 24.9 | 49 | ||
| TIA1 | + | + | 23.4 | 53 | + | Welander distal myopathy |
| HNRNPA1L2 | + | + | 22.8 | 57 | ||
| HNRNPH1 | + | + | 22.2 | 63 | ||
| DDX5 | − | + | 21.2 | 73 | + | |
| PSF | + | + | 20.8 | 79 | FTLD | |
| HNRNPA0 | + | + | 20.5 | 81 | ||
| HNRNPH2 | + | + | 17.5 | 101 | ||
| DAZ2 | + | + | 16.2 | 119 | ||
| RBM14 | + | + | 16.0 | 122 | ||
| CSTF2 | + | + | 15.7 | 126 | ||
| TNRC6C | − | + | 15.4 | 128 | + | |
| SOX2 | − | + | 15.0 | 135 | ||
| CAPRIN1 | − | + | 14.9 | 136 | + | |
| DROSHA | − | + | 14.8 | 137 | ||
| DDX17 | − | + | 14.8 | 139 | ||
| DAZ3 | + | + | 14.6 | 144.5 | ||
| DAZ2 | + | + | 14.6 | 144.5 | ||
| DAZ1 | + | + | 14.1 | 148 | ||
| HNRNPH3 | + | + | 14.0 | 151 | ||
| CSTF2T | + | + | 14.0 | 153 | ||
| CELF4 | + | + | 13.8 | 156 | ||
| TIAL1 | + | + | 13.6 | 162 | + | |
| RBM33 | + | + | 12.9 | 178 | ||
| DLX2 | − | + | 12.5 | 188 | ||
| DAZAP1 | + | + | 11.7 | 203 | ||
| SUPT6H | − | + | 11.6 | 206 | ||
| ATXN2 | − | + | 10.2 | 227 | + | SCA2, ALS |
| DHX9 | − | + | 10.1 | 230 | ||
| PSPC1 | + | + | 10.0 | 231 | ||
| GAR1 | − | + | 9.4 | 235 | ||
| SF1 | − | + | 9.4 | 236 | ||
| FUBP1 | − | + | 9.2 | 237 | ||
| EIF4G3 | − | + | 8.5 | 243 | + | |
| EIF4G1 | − | + | 8.3 | 246 | + | PD |
| Protein | RRM domain (Pfam PF00076) | RNA binding (GO:0003723) | Prion domain score | Prion domain rank | P-bodies and/or SGs? | Neurodegenerative disease? |
| TNRC6A | − | + | 42.1 | 9 | + | |
| FUS | + | + | 38.5 | 12 | + | ALS, FTLD |
| ATXN1 | − | + | 35.5 | 15 | SCA1 | |
| TAF15 | + | + | 33.2 | 22 | + | ALS, FTLD |
| EWSR1 | + | + | 32.3 | 25 | + | ALS, FTLD |
| HNRPDL | + | + | 31.5 | 27 | ||
| HNRNPD | + | + | 30.7 | 29.5 | ||
| HNRNPA2B1 | + | + | 29.9 | 32 | + | IBMPFD |
| ILF3 | − | + | 29.8 | 33 | ||
| HNRNPUL1 | − | + | 28.5 | 37 | ||
| HNRNPA1 | + | + | 28.2 | 38 | + | IBMPFD, ALS |
| HNRNPAB | + | + | 27.8 | 39 | ||
| HNRNPA3 | + | + | 27.2 | 41 | + | C9orf72 ALS/FTLD |
| TARDBP | + | + | 26.5 | 43 | + | ALS, FTLD |
| HNRNPU | − | + | 24.9 | 49 | ||
| TIA1 | + | + | 23.4 | 53 | + | Welander distal myopathy |
| HNRNPA1L2 | + | + | 22.8 | 57 | ||
| HNRNPH1 | + | + | 22.2 | 63 | ||
| DDX5 | − | + | 21.2 | 73 | + | |
| PSF | + | + | 20.8 | 79 | FTLD | |
| HNRNPA0 | + | + | 20.5 | 81 | ||
| HNRNPH2 | + | + | 17.5 | 101 | ||
| DAZ2 | + | + | 16.2 | 119 | ||
| RBM14 | + | + | 16.0 | 122 | ||
| CSTF2 | + | + | 15.7 | 126 | ||
| TNRC6C | − | + | 15.4 | 128 | + | |
| SOX2 | − | + | 15.0 | 135 | ||
| CAPRIN1 | − | + | 14.9 | 136 | + | |
| DROSHA | − | + | 14.8 | 137 | ||
| DDX17 | − | + | 14.8 | 139 | ||
| DAZ3 | + | + | 14.6 | 144.5 | ||
| DAZ2 | + | + | 14.6 | 144.5 | ||
| DAZ1 | + | + | 14.1 | 148 | ||
| HNRNPH3 | + | + | 14.0 | 151 | ||
| CSTF2T | + | + | 14.0 | 153 | ||
| CELF4 | + | + | 13.8 | 156 | ||
| TIAL1 | + | + | 13.6 | 162 | + | |
| RBM33 | + | + | 12.9 | 178 | ||
| DLX2 | − | + | 12.5 | 188 | ||
| DAZAP1 | + | + | 11.7 | 203 | ||
| SUPT6H | − | + | 11.6 | 206 | ||
| ATXN2 | − | + | 10.2 | 227 | + | SCA2, ALS |
| DHX9 | − | + | 10.1 | 230 | ||
| PSPC1 | + | + | 10.0 | 231 | ||
| GAR1 | − | + | 9.4 | 235 | ||
| SF1 | − | + | 9.4 | 236 | ||
| FUBP1 | − | + | 9.2 | 237 | ||
| EIF4G3 | − | + | 8.5 | 243 | + | |
| EIF4G1 | − | + | 8.3 | 246 | + | PD |
49 human RNA-binding proteins (containing the Pfam RRM [PF00076] and/or annotated with the GO term for RNA-binding [GO:0003723]) also harbor predicted prion-like domains. Prion score, based on Alberti et al. (2009), indicates the maximum log-likelihood ratio for prion-like amino acid composition vs. non–prion-like amino acid composition in any 60 consecutive amino acid window contained in a region parsed as prion-like by the hidden Markov model. Prion domain rank is from 21,873 human proteins, 250 of which had positive prion score. Localization to P-bodies or SGs is based on literature searches, especially Buchan and Parker (2009). Human disease connections for select proteins are indicated.
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.